Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa—Fourth investigation: The effect of increasing the dosage of isoniazid

作者: ACOOPERATIVECONTROLLEDSTUDYI

DOI: 10.1016/S0041-3879(66)80018-1

关键词:

摘要: Summary This report gives the results of a controlled study for 12 months of: o (a)the effects increasing dosage isoniazid from 300 mg. to 450 in combination with thiacetazone 150 mg., (b)the role an initial two hospital compared out-patient treatment start, (c)the value routine surprise home visits per month no such visits. Between February 1963 and June 1964, 373 patients were allocated at random eight subgroups formed (a), (b) (c) above. The pretreatment findings similar most respects they have therefore been combined make following comparisons: A.of drug regimens TH300 series: Thiacetazone plus daily. TH450 pyridoxine 6 B.of in- IN An followed by treatment. OUT Out-patient start. C.of visiting HV Two each month. No Results are presented 251 who had isoniazid-sensitive strains tubercle bacilli complied clinical criteria admission. Fourteen died, nine (three TH300, six TH450) active tuberculosis, three (one unestablished cause but one (TH450), without evidence non-tuberculous cause, (TH450) death was attributed toxicity. sputum culture negative 81% 77% 79% 68% respectively, statistically non-significant differences. At 71% 17 19 positive cultures isoniazid-resistant strains. In second 67% 78 resistant series, as 83% 89 series. sensitivity tests yielded emergence resistance both geometric mean 29 series 1·07 2·25 μg./ml. respectively (P=0·002). status classified mainly on basis 10, 11 months; 109 favourable 102 TH450, difference; 76% 110 101 status, 74% 72% status. first four (3%) 159 in-patients defaulted did 75 out-patients (OUT/HV series), 13 (15%) 88 (OUT/No series); this difference attains statistical significance (P Drug toxicity reported (2·5%) side-effects 360 patients, (0·3%) reactions possibly drugs. It is concluded (a) that single daily dose not more effective than dose, little, if any, influence response treatment, reduced default early started out-patients.

参考文章(14)
H. Stott, C. V. Ramakrishnan, Wallace Fox, S. Devadatta, S. Velu, J. J. Y. Dawson, P. R. Somasundaram, S. Radhakrishna, S. P. Tripathy, A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS Bulletin of The World Health Organization. ,vol. 34, pp. 533- 551 ,(1966)
P R J Gangadharam, T Subbaiah, C Narayanan Nair, A simple paper test for isoniazid in urine Tuberculosis Association of India. ,(1962)
Stig Andersen, D. Banerji, A SOCIOLOGICAL INQUIRY INTO AN URBAN TUBERCULOSIS CONTROL PROGRAMME IN INDIA. Bulletin of The World Health Organization. ,vol. 29, pp. 685- 700 ,(1963)
W.F. Tyrrell, BED REST IN THE TREATMENT OF PULMONARY TUBERCULOSIS The Lancet. ,vol. 267, pp. 821- 823 ,(1956) , 10.1016/S0140-6736(56)91294-6
D.M. Macfadyen, J.M.L. Klopper, S.P.N. Shongwe, Tuberculosis treatment in the Hlatikulu District of Swaziland Tubercle. ,vol. 44, pp. 82- 86 ,(1963) , 10.1016/S0041-3879(63)80062-8
N. Wynn-Williams, J. Brian Shaw, Is cavity closure in pulmonary tuberculosis influenced by bed-rest? Tubercle. ,vol. 41, pp. 352- 357 ,(1960) , 10.1016/S0041-3879(60)80037-2
L. Šula, Miloslava Langerová, D. A. Mitchison, P. Hauduroy, S. Froman, G. Canetti, Gertrud Meissner, H. T. Mahler, J. Grosset, Mycobacteria: laboratory methods for testing drug sensitivity and resistance Bulletin of The World Health Organization. ,vol. 29, pp. 565- 578 ,(1963)